Adial Pharmaceuticals, Inc. (ADIL) vs IN8bio, Inc. (INAB)
A side-by-side comparison of Adial Pharmaceuticals, Inc. and IN8bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADIL
Adial Pharmaceuticals, Inc.
$4.23HealthcareDelayed quote: Oct 6, 2026, 12:51 PM EDT
INAB
IN8bio, Inc.
$1.43HealthcareDelayed quote: Oct 6, 2026, 12:53 PM EDT
Total return — ADIL vs INAB
growth of $100 · dividends reinvested · last 5yADIL -99.7% (-69.0%/yr)INAB -99.5% (-65.7%/yr)INAB compounded faster over this window
ADIL INAB
ADIL vs INAB: by the numbers
- •INAB is the larger company ($14M vs $11M market cap).
Metrics side by side
Valuation
| Metric | ADIL | INAB |
|---|---|---|
| P/B ratio | N/A | 0.75 |
Profitability
| Metric | ADIL | INAB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -37052.06% | -101.66% |
| ROIC | -240.64% | -91.74% |
Growth (annualized)
| Metric | ADIL | INAB |
|---|---|---|
| Total return CAGR (5Y) | -71.86% | -62.88% |
Frequently asked
- How have ADIL and INAB total returns compared?
- Over the past 5 years, ADIL delivered -71.86% and INAB delivered -62.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.